| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695749 | Gynecologic Oncology | 2017 | 10 Pages |
Abstract
CXCL10 is a positive determinant of anti-tumour immune responses in HGSC TME and disease progression. These findings are foundational for future translational studies aimed at improving treatment response and survival in HGSC patients, via exploiting the TME.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Katrina K. Au, Nichole Peterson, Peter Truesdell, Gillian Reid-Schachter, Kasra Khalaj, Runhan Ren, Julie-Ann Francis, Charles H. Graham, Andrew W. Craig, Madhuri Koti,